Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson May 26, 2020 7:58pm
130 Views
Post# 31075702

RE:RE:RE:RE:RE:News tomorrow??

RE:RE:RE:RE:RE:News tomorrow??

Undervalued in what respect? The comparable companies MIR, SONA, etc all produce and Develop the tests. SZLS is a lab providing a service. We don't know revenue numbers in terms of revenue per unit, we don't know how many tests in a day, we don't know much. Everything is speculation. Why? Your guess is as good as mine. My opinion, keep it vague, and you don't even have to process 5 a day and you are still doing what you said you would.


SAGDollar wrote: As IR stated and I previously quoted 

"The lab is not bottled necked at all. We are processing results. I get the impression that the market envisions the testing like a bottle factory, but with social distancing sample collection presents certain challenges. We are ramping up but I would expect some ebb and flow in the daily numbers. Hence a more realistic idea will be hitting milestones and quarterly numbers."

After digesting this I do not think we are doing 1000 tests a day due to logistical delays associated with covid. I think once we get an established influent of tests we will be well exceeding the 1000 tests per day hence the reasoning behind the proposed lab expansion. I agree numbers speak louder than words, and I hope just as much as the next person to see numbers soon. All I know is that if we have even started processing 100 tests per day we are SEVERELY UNDERVALUED. 

 

Bullboard Posts